Ausgabe 5/2001
Inhalt (12 Artikel)
Commentary
Reporting sexual function disorders caused by antipsychotic drugs: is there a role for the community pharmacy?
C.A.W. Rijcken, J.A.M. Dekens‐Konter, L.T.W. de Jong‐van den Berg, H. Knegtering
Patients' opinions of CFC‐free inhaler changeover in primary care
F. Arris, L. Thorburn, D.J. McCaig
Pharmaceutical care needs of patients with angina
E.M. McGovern, C. Mackay, A. Hair, H. Lindsay, S.M. Bryson
Evaluation of the implementation of a local treatment guideline in secondary prevention post-myocardial infarction
F. Reid, B. Fossland, A.D. Flapan, C.C. Duckelmann, S.A. Hudson
Identification of the pharmaceutical care issues of rheumatoid arthritis patients in secondary care
R. O'Hare, A. Muir, S. Chapman, A. Watson, S.A. Hudson
Patients' evaluation of shape, size and colour of solid dosage forms
A.B.A. Overgaard, J. Møller‐Sonnergaard, L.L. Christrup, J. Højsted, R. Hansen
The pharmaceutical care of patients with hypertension: an examination of service models in primary care in the US
J.J. McAnaw, S.A. Hudson, A‐M. McGregor
Nursing and residential care for the elderly in Northern Ireland: the contribution of the pharmacist
Anna K. Schweizer, Carmel M. Hughes
Gentamicin pharmacokinetics in preterm infants with a patent and a closed ductus arteriosus
D.J. Touw, J.H. Proost, R. Lafeber, H.N. Stevens, M.M. van Weissenbruch